REVERSE-Long COVID-19 With Baricitinib Study

Clinical trial NCT05858515 · WITHDRAWN

Trial details

NCT number: NCT05858515
Sponsor: Vanderbilt University Medical Center
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Acute COVID-19 Syndrome

Start date: 2024-10-21
Primary completion: 2027-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.